You searched for tofacitinib

Your search for tofacitinib returned 2 results

Sort Results:

Relevant Recent

ACR/ARHP Annual Meeting 2013

Tofacitinib, A Viable Option for Moderate-to-Severe Rheumatoid Arthritis

October 29, 2013

Tofacitinib may be a viable option for patients with moderate-to-severe rheumatoid arthritis, according to a systematic review and meta-analysis reported at the 2013 ACR/ARHP Annual Meeting.

ACR/ARHP Annual Meeting 2013

Twice-Daily Tofacitinib Shows Sustained Efficacy Over 5 Years in RA

October 30, 2013

Tofacitinib 5mg or 10mg twice daily showed a consistent safety profile and sustained efficacy over 5 years in long-term extension studies for patients with rheumatoid arthritis, as presented at the 2013 ACR/ARHP Annual Meeting.

Your search for tofacitinib returned 2 results

Active Filters

Tofacitinib, A Viable Option for Moderate-to-Severe Rheumatoid Arthritis

Twice-Daily Tofacitinib Shows Sustained Efficacy Over 5 Years in RA